Ergoteles’s Amedisys AMED Stock Holding History

Ergoteles’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$3.16M	Sell	33,863 -4,781	-12%	-$442K	4.64%	7
2023 Q2	$3.53M	Buy	38,644 +24,606	+175%	+$2.02M	0.17%	143
2023 Q1	$1.03M	Sell	14,038 -3,193	-19%	-$276K	0.04%	488
2022 Q4	$1.44M	Buy	+17,231	New	+$1.55M	0.05%	360
2022 Q3	–	Sell	-12,729	Closed	-$1.34M	–	1525
2022 Q2	$1.34M	Buy	12,729 +8,950	+237%	+$1.14M	0.04%	427
2022 Q1	$651K	Buy	+3,779	New	+$565K	0.02%	574
2021 Q3	–	Sell	-2,300	Closed	-$563K	–	1170
2021 Q2	$563K	Sell	2,300 -5,700	-71%	-$1.5M	0.01%	750
2021 Q1	$2.12M	Buy	8,000 +5,155	+181%	+$1.45M	0.07%	274
2020 Q4	$835K	Buy	+2,845	New	+$729K	0.03%	360

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Ergoteles's AMED Position: Q3 2023 in Review

Ergoteles reduced its Amedisys (AMED) stake by 12% in Q3 2023, selling an estimated $442K and leaving 33,863 shares worth $3.16M. The position accounts for 4.64% of the portfolio, ranked #7.

Ergoteles first reported a position in AMED in Q4 2020 and has held it in 9 quarters since. The position peaked at $3.53M in Q2 2023. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

Ergoteles held 33,863 shares of Amedisys worth $3.16M as of Q3 2023.
Ergoteles sold 4,781 Amedisys shares in Q3 2023, an estimated $442K.
Amedisys made up 4.64% of Ergoteles's portfolio in Q3 2023, its #7 holding.
Ergoteles first reported a position in Amedisys in Q4 2020 and has held it in 9 quarters since.
Ergoteles's Amedisys position peaked at $3.53M in Q2 2023.
286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.